Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

including smaller research labs and institutions with limited budgets. This could lead to an expansion of 10x Genomics' market share and help offset some of the challenges faced in other product ...

The Chromium Xo, being more affordable than some of the company's other offerings, could attract a broader customer base, including smaller research labs and institutions with limited budgets. This ...

The NIH projected the cut will save it $4 billion during the current federal fiscal year, which ends September 30. That’s ...

Preliminary rendering of 10x Genomics’ planned development at the former Pleasanton ... The first building is scheduled to open next year, and include clean rooms for labs as well as office space. The ...

We read every piece of feedback, and take your input very seriously.

Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received a consensus recommendation of “Hold” from the seventeen analysts ...

Genomics (NASDAQ:TXG – Get Free Report) is projected to announce its earnings results after the market closes on Thursday, February 20th. Analysts expect 10x Genomics to post earnings of ($0.29) per ...